Valeant Acquires Fellow Pharma Co. Salix In $14.5B Deal
Valeant Pharmaceuticals International Inc. has locked in a deal to buy gastrointestinal drugmaker Salix Pharmaceuticals Ltd. for about $14.5 billion including debt, the companies revealed on Sunday, in a mega-merger meant...To view the full article, register now.
Already a subscriber? Click here to view full article